ODYSSEE ANESTHESIA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ODYSSEE ANESTHESIA
Largest movements
- Deferred charges and accrued income -€27,686
down €27,686 (-81.3%), from €34,048 to €6,362
- Cash +€18,396
up €18,396 (+22.7%), from €81,059 to €99,455
mainly Other debts (+€81,326) and Net result for the year (+€30,528)
- Profit (loss) carried forward -€90,305
no longer reported in 2025 (was €90,305)
- Other debts +€81,326
new in 2025: €81,326
- Gross operating margin -€10,464
down €10,464 (-19.0%), from €55,207 to €44,743
- Taxes -€2,174
down €2,174 (-17.7%), from €12,254 to €10,080
- Other operating charges +€698
up €698 (+54.2%), from €1,287 to €1,985
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €124,503 | €115,083 | -€9,420 | -7.6% |
| Fixed assets | 21/28 | €1,266 | €678 | -€588 | -46.4% |
| Tangible fixed assets | 22/27 | €1,266 | €678 | -€588 | -46.4% |
| Plant, machinery and equipment | 23 | €1,122 | €678 | -€444 | -39.5% |
| Furniture and vehicles | 24 | €144 | - | -€144 | |
| Current assets | 29/58 | €123,237 | €114,405 | -€8,832 | -7.2% |
| Amounts receivable within one year | 40/41 | €8,131 | €8,589 | +€458 | +5.6% |
| Other amounts receivable | 41 | €8,131 | €8,589 | +€458 | +5.6% |
| Cash at bank and in hand | 54/58 | €81,059 | €99,455 | +€18,396 | +22.7% |
| Deferred charges and accrued income | 490/1 | €34,048 | €6,362 | -€27,686 | -81.3% |
| Total equity and liabilities | 10/49 | €124,503 | €115,083 | -€9,420 | -7.6% |
| Equity | 10/15 | €117,918 | €27,613 | -€90,305 | -76.6% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Reserves | 13 | €26,613 | €26,613 | = | 0.0% |
| Distributable reserves | 133 | €26,613 | €26,613 | = | 0.0% |
| Profit (loss) carried forward | 14 | €90,305 | - | -€90,305 | |
| Amounts payable | 17/49 | €6,586 | €87,471 | +€80,885 | +1,228% |
| Amounts payable within one year | 42/48 | €6,586 | €87,471 | +€80,885 | +1,228% |
| Trade debts | 44 | €6,586 | €6,145 | -€441 | -6.7% |
| Suppliers | 440/4 | €6,586 | €6,145 | -€441 | -6.7% |
| Other amounts payable | 47/48 | - | €81,326 | +€81,326 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €610 | €588 | -€22 | -3.6% |
| Other operating charges | 640/8 | €1,287 | €1,985 | +€698 | +54.2% |
| Gross operating margin | 9900 | €55,207 | €44,743 | -€10,464 | -19.0% |
| Operating profit (loss) | 9901 | €53,310 | €42,169 | -€11,140 | -20.9% |
| Financial income | 75/76B | €737 | €531 | -€207 | -28.0% |
| Recurring financial income | 75 | €737 | €531 | -€207 | -28.0% |
| Financial charges | 65/66B | €2,242 | €2,093 | -€149 | -6.6% |
| Recurring financial charges | 65 | €2,242 | €2,093 | -€149 | -6.6% |
| Profit (loss) for the period before taxes | 9903 | €51,806 | €40,608 | -€11,198 | -21.6% |
| Income taxes | 67/77 | €12,254 | €10,080 | -€2,174 | -17.7% |
| Profit (loss) for the period | 9904 | €39,552 | €30,528 | -€9,024 | -22.8% |
| Profit (loss) for the period to be appropriated | 9905 | €39,552 | €30,528 | -€9,024 | -22.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.